Skip to main content
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. — Investor Relations & Filings

Ticker · SCNX ISIN · US89846A2078 US Manufacturing
Open in API
Filings indexed 495 across all filing types
Latest filing 2018-02-14 Director's Dealing
Country US United States of America
Listing US SCNX

About Scienture Holdings, Inc.

https://www.trxadehealth.com/

Scienture Holdings, Inc. is a holding company that operates through its subsidiaries, including Scienture, LLC and Integra Pharma Solutions, LLC. The company functions as an integrated pharmaceutical and health services provider focused on the development, commercialization, and distribution of novel specialty products. A key therapeutic area includes treatments for central nervous system disorders. Scienture Holdings aims to enhance value for patients and physicians by addressing the needs of underserved populations and bridging gaps in treatment delivery systems to improve healthcare outcomes. The company also provides a web-based purchasing platform for transactions.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2018-02-14 English
PRIMARY DOCUMENT
Director's Dealing
2018-02-14 English
PRIMARY DOCUMENT
Director's Dealing
2018-02-14 English
PRIMARY DOCUMENT
Director's Dealing
2018-02-12 English
FORM 10-Q QUARTERLY REPORT
Interim / Quarterly Report Q3 2017
2017-11-07 English
DEFINATIVE 14C INFORMATION STATEMENT
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled 'DEF 14C' and is described as a 'Definitive Information Statement' pursuant to Section 14(c) of the Securities Exchange Act of 1934. It includes details about the Annual Meeting of Stockholders, including the date, location, agenda items such as election of directors and ratification of auditors, and voting instructions. It explicitly states it is not soliciting proxies but provides information relevant to the meeting. The document also includes biographies of director nominees and other meeting-related information. This matches the description of a Proxy Solicitation & Information Statement, which is material sent to shareholders to provide information and request votes for meetings. It is not an Annual Report, Earnings Release, or other financial report. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI). The document length and content support a high confidence level.
2017-10-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.